S100-positive T lymphocytes account for less than 3% of peripheral blood T cells. Rare cases of S100-positive T-cell lymphoma have been previously described. We report four such cases of S100-positive T-cell chronic lymphoproliferative disease. In all cases, hepatosplenomegaly was observed, without prominent lymphadenopathy. Central nervous system (CNS) involvement by the leukemic cells was suggested in three cases by physical symptoms and confirmed in two cases by cerebrospinal fluid studies. Despite treatment, three patients died at 3,6, and 8 months after diagnosis. Although there was a leukemic presentation, only minimal bone marrow infiltration was evident. Splenectomy showed red pulp infiltration. Liver and lymph node biopsies showed sinusoidal leukemic involvement. In all cases, the leukemic cells HRONIC lymphoproliferative disorders include a vari-
C ety of entities having unique morphologic, clinical, and immunologic features.' In general, these lymphoproliferative neoplasms correspond to particular subsets of normal B and T lymphocytes as defined by immunologic marker
The T-cell chronic lymphoproliferative disorders are not as frequently encountered as their B-cell counterparts and include "true" T-cell chronic lymphocytic leukemia,' T-y lymphoproliferative disorder (large granular lymphocytosi~),4.~ peripheral T-cell lymphoma: adult T-cell leukemia/lymphoma (human T-cell lymphotropic virus type-1 [HTLV-11 associated),' and mycosis fungoides/ Sezary syndrome. ' A newly recognized and poorly understood subset of peripheral blood (PB) T lymphocytes has been shown to contain cytoplasmic SlOOP protein. ' .'' These S100-positive T lymphocytes typically comprise less than 3% of circulating mononuclear cells and have a suppressor immunophenotype, with expression of CD2, CD8, and CDllb."- '4 In normal thymus, small lymphocytes with SlOOP immunoreactivity can be found in both the cortex and medulla." In addition, small numbers of S100P-positive small lymphocytes can be found in splenic red pulp, as well as in the mucosa of the small intestine.I6 The nature and origin of S100P-positive lymphocytes remain obscure. Although these cells have a suppressor immunophenotype, their role in normal T-cell function remains an enigma.
Two cases of S100-positive T-cell lymph~ma"~'~ and one case of S100-positive T-cell leukemia have been previously reported." All three of these patients had organomegaly without prominent lymphadenopathy and their disease was characterized by an aggressive clinical course, central nervous system (CNS) involvement by the malignant cells, and relatively short survivals of 15 months or le~s.''~'~ We have identified four more such cases of S100-positive T-cell chronic lymphoproliferative disease (S100-CLPD).
In the present study, we have more extensively reported the morphologic features, immunophenotyping studies, molecular assays, functional studies, and virologic assays to more precisely characterize this fascinating yet poorly understood disorder. The initial diagnosis of an S100-positive lymphoproliferation in case no. 1 prompted the search for expressed mature T-cell-and natural killer cell-associated antigens. Cytoplasmic SlOO was detected in the leukemic cells in the blood, spleen, liver, and lymph node. Southern blot studies in two cases showed T-p, T-y, and T-6 gene rearrangements. RNA Northern blots showed T-a and T-p chain transcripts with no T-7 or T-6 RNA identified. Southern blot analysis showed no hybridization to probes specific for Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus-1, or human T-cell lymphotropic virus type-1. These findings show that S100-positive T-cell chronic lymphoproliferative disorder is an aggressive, extramedullarybased disease frequently associated with CNS involvement and characterized by short survivals. December 6, 1988 , after placement of a ventricular-peritoneal shunt, the patient experienced a left frontal lobe hemorrhage and became unresponsive. After a lengthy course in the intensive care unit without significant improvement, the patient died on January 4, 1989 , approximately 1 year after seeking medical care and 6 months after being diagnosed with a chronic leukemia.
MATERIALS AND METHODS

Case Selection
The case population for this study consisted of four patients selected from the fdes of the Hematopathology and Flow Cytometry Laboratories at the University of Michigan. Two patients were treated and followed-up at the University of Michigan Hospital; the other two patients were referral cases sent to the Laboratory for consultation and further characterization.
Blood and BM
In all cases, PB smears, BM aspirate smears, and BM trephine biopsy sections were obtained for morphologic evaluation. PB and BM aspirate smears were evaluated after Wright's or Wright'sGiemsa stain. Cytochemical stains were performed on blood or BM smears (cases no. 1 and 2) and included myeloperoxidase, Sudan black-B, nonspecific esterase, and periodic acid-Schiff. BM trephine biopsy specimens were fixed in either B-5 or neutral buffered formalin and processed by routine methods6 Ultrastructural studies on PB were performed in case no. 1 using standard procedures, as previously described.m
Tissues
Lymph node (cases no. 1 and 2), spleen (case no. l), and liver (case no. 1) tissues were submitted fresh and were immediately fixed in B-5 and/or neutral buffered formalin. The tissues were then processed routinely, and sections stained with hematoxylin and eosin. A portion of each lymph node and spleen were snap-frozen in liquid nitrogen and then stored at -70°C for subsequent immunohistochemical and molecular analytical studies.
Flow Cytometry
Immunophenotypic analysis of PB was performed by flow cytometry in all cases; single cell suspensions from lymph node biopsies were also evaluated in cases no. 1 
Immunohistochemisny
Immunohistochemical analyses of paraffin sections were performed on B5 or formalin-fixed tissues. The antisera used included: CD45 (LCA); L-26; CD74 (LN2); CDw75 (LNl); Ig heavy and light chains; CD45RO (UCHL-1); MT1; CD15 (Leu-Ml); CD68 (KP1); lysozyme; a-antichymotrypsin; desmin; vimentin; cytokeratin; epithelial membrane antigen (EMA); and anti-Sl00p. An avidin-biotinperoxidase complex technique was used with all antisera." Immunoalkaline phosphatase studies with anti-Sl00p were performed on PB smears in cases no. 1, 3, and 4.' Appropriate positive and negative controls were used for all immunohistochemical studies.
Molecular Analyses
The DNA used for gene rearrangement studies and RNA for Northern blot studies were extracted from blood and tissue specimens from cases no. 1 and 2 according to previously described standard proced~res."~~~
Molecular Gene Probes
Ig gene probes used in this study consisted of a 6.0-kb BamHIl HindIII fragment containing the joining region of the Ig heavy chain gene (JH). Analysis of J, was performed with DNA digested with BamHI and HindIII. The TCR gene probes used included a 0.77-kb cDNA from the T-p chain gene constant regions, 0.6-kb fragments from the joining region of the T-y gene, and a 1.5-kbXba I genomic fragment from the joining region of the T-6 gene. BamHI-, EcoRI-, and HindIII-digested DNA were evaluated with the various TCR probes.
viral Genomic Studies
DNA obtained from PB lymphocytes of cases no. 1 and 2 was probed via Southern blot hybridization for the presence of viral genomic DNA of the human retroviruses, human immunodeficiency virus-1 (HIV-l), and HTLV-1. Probes corresponded to the highly conserved gag regions of both viruses. Binding to positive controls were used with both probes.
DNA hybridization studies for two herpesviruses were also performed. An EBV probe was derived from the 9.0-kb BamHI W fragment of the B95-8 strain of EBV." The CMV probe used was constructed from the 32-kbBa I C fragment of the Towne strain of CMV.)' Control DNA obtained from an EBV-positive lymphoma and CMV-positive brain tissue showed binding of EBV-and CMV-specific probes, respectively. Cytotoxicity assays were performed in duplicate. After 3 hours of incubation, the supernatant was harvested and the radioactivity was determined with a gamma counter. The results were expressed as the mean percent of "Cr release.
Cytotoxicity Assay
RESULTS
Clinical and Laboratoiy Findings
The major clinical and laboratory findings are summarized in Table 1 . The four patients included three men and one woman, with ages ranging from 29 to 62 years (median, 45 years). Three of the four patients had constitutional symptoms of fatigue and fever. The fourth patient (case no. 1) had epistaxis and a petechial rash. None of the four patients had lymphadenopathy, although two patients (cases no. 1 and 2) eventually developed small palpable nodes during the course of their disease. In contrast, massive splenomegaly was present in all four patients and three of the four patients had significant hepatomegaly. One patient (case no. 1) undenvent splenectomy to treat a presumed immune thrombocytopenic purpura, refractory to steroids. No cutaneous involvement was noted on physical examination in any of these patients. No signs of CNS involvement were noted at presentation.
Leukocytosis was present in all four patients with the W C ranging from 18.5 to 411.0 x 109/L (median, 45.5 x 109/L). A relative and absolute lymphocytosis was present in all four patients with the lymphocyte percentage ranging from 62% to 95% of the overall WBC (median, 73.5%). No anemia was noted in three of the four patients, with the Hct ranging from 45% to 51% (median, 48%); the Hb ranged from 12.5 gm/dL to 14.0 gm/dL (median, 13.5 gm/dL). In contrast, all had thrombocytopenia at presentation, ranging from 9 to 122 x 109/L (median, 41 x 109/L). Liver function tests were elevated in all four patients to varying degrees. Serum calcium levels were normal to slightly decreased, ranging from 8.8 to 10.0 mg/dL.
CSF studies were performed in three of the patients at the time of diagnosis; all three were unremarkable at this time. However, three of the four patients (cases no. 1, 2, and 3) eventually developed signs of CNS involvement with symptoms of headache, confusion, and drowsiness. Two of these three patients had lumbar puncture studies performed. Both CSF samples showed a significant lymphocytosis, 55 and 95 W C / m m 3 . Cytologically, the lymphocytes were atypical in appearance and consistent with neoplastic involvement. 
Molphology
PB. Morphologic examination of the PB showed a moderate lymphocytosis in three of the four cases (nos. 1,2, and 3). The lymphocytes in all cases were heteromorphous in appearance and varied from small to intermediate in size (Fig 1) . The nuclei were basically round in shape but occasionally exhibited an irregular nuclear outline, ranging from slight nuclear folding to obvious nuclear convolutions. The nuclear chromatin appeared coarsely clumped in these lymphocytes. Some of these atypical lymphocytes had a monocytoid-like appearance. Only rare hyperlobulated or mulberry-shaped nuclei typical of adult T-cell leukemia/ lymphoma were seen.' Nucleoli were small and inconspicuous. Cytoplasm was relatively abundant and amphophilic to slightly basophilic in appearance. No cytoplasmic granules were seen in any of the leukemic cells, although rare granular lymphocytes could be identified on the smears. During the course of disease in patient no. 1, the morphologic characteristics of the lymphocytes changed and acquired more of a prolymphocytoid appearance (Fig 1) . These cells had finely reticular chromatin and contained one or two prominent nucleoli. All cases had striking thrombocytopenia. Interestingly, mild anemia was noted in only one case; the other three cases had normal Hb/Hct values. RBC morphology was normal in all cases.
BM aspirates in all cases appeared normocellular to slightly hypercellular. Only a minimal increase in lymphocytes (up to 10%) was identified. Erythroid and granulocytic precursors appeared unremarkable and showed normal maturation. The BM trephine biopsies from all cases appeared slightly hypercellular with only scattered interstitial lymphocytes seen. Megakaryocytes were easily identified, suggesting that the thrombocytopenia was due to peripheral destruction. No marrow involvement with leukemia could be definitively identified in the biopsy sections.
Evaluation of the CSF in cases no. 1 and 2 showed a lymphocytosis with lymphocytes similar to those described in the PB. These cells were quite distinct from the background, normal lymphocytes and monocytes in the CSF.
The spleen from patient no. 1, which was removed 3 months before his leukemic presentation, was enlarged to four times normal size (980 g) with an expanded red pulp and normalappearing white pulp. Microscopic sections showed congestion of the red pulp with an inconspicuous lymphoid infiltrate that was difficult to recognize morphologically. A needle biopsy of liver from case no. 1 showed a difise, sinusoidal infiltrate composed of small, lymphoid-appearing cells having round to slightly irregular nuclei, coarse BM aspirate and trephine biopsy sections.
CSF.
Spleen, liver, and lymph node tissue sections.
For chromatin, and faint nucleoli (Fig 2) . No distinct lymphoid nodulcs wcrc idcntificd. Thc hcpatocytcs in this biopsy appcarcd unrcmarkablc with somc bilc stasis notcd.
Lymph nodc biopsies in caws no. 1 and 2 showcd diffusc sinusoidal infiltratcs in both subcapsular and medullary sinuses. Thc sinusoidal infiltratcs encroached on the Cortical areas of thc lymph nodc with somc comprcssion of normal folliclcs. Thc ncoplastic cclls within thc lymph nodc sinuses had a similar appcarancc to those dcscribcd in the PB smcars and livcr biopsy (Fig 2) .
Ultrastructural studicsof the PB lymphocytcs in casc no. 1 showcd cclls with abundant cytoplasm and round to slightly irrcgular nuclci. Only small nuclcoli wcrc disccrncd. Occasional clcctron-dcnsc granules with palc matrix matcrial and poorly dcfincd tubulorcticular structurcs wcrc sccn within thc cytoplasm (Fig 3) ." Highcr resolution of thcsc particlcs did not confirm thc prescncc of any capsid-likc structure. No parallel tubular arrays were identified, as havc bccn charactcristically found in largc granular lymphocytcs.'
Immtmophenotyping
Flow qtomcty Flow cytomctric immunophcnotyping rcsults arc summarizcd in Tablc 2. Two pan-T-ccll antigens, CD2 and CD3, were identified in the majority of lcukcmic cclls in all four cascs; CD7 was identified in two of two cascs. Anothcr pan-T-cell marker, CD5, was idcntificd in two of four cascs. CD4 and CD8 wcrc csscntially ncgativc in all cases with only residual normal lymphocytcs showing staining. Intcrcstingly, no staining was sccn with WT31 (TCR-I). This antibody rccognizcs a confirmational cpitopc of thc T-ccll a / p rcccptor." Thc combination of CD3 positivity and WT31/CD4/CD8 negativity has usually bccn cquatcd with cclls cxprcssing a y/b TCR rather than the morc common a/P TCR."" Howcvcr, MoAbs directed against the T-y (TCRy-1) and T-8 (TCR8-1) rcccptor chains failed to show any staining.
Scvcral NK ccll-associated markers wcrc cxprcsscd in thcsc cascs. C D l l b and CD16 wcrc exprcsscd in thc majority of lcukcmic cclls in all thrcc caws studicd. CDS6 was idcntificd in two CaSCS and CD1 IC in one cast, rcspcctivcly. CDS7 was abscnt in all thrcc caws studicd. AI1 B-ccll-assmiatcd and mycloid-associatcd MoAbs failed to show any significant reactivity.
A similar immunophcnotypc as dcscribcd abovc was also found with frozcn section studies of lymph nodc biopsies from cases no. 1 and 2. Thcsc biopsics included rcactivity with Ultrustmcttire.
Lymph node frozen section immunophenotyping.
For CD2. CD3, CD7, CDIlb. and CD56. The staining pattern was primarily sinusoidal. CD4 and CD8 reactivity was limited to uninvolved paracortical regions. The germinal centers showed polyclonal Ig staining. In addition, several TCR MoAbs werc used on frozen SCCtiOnS Of cases no. 1 and 2. These results are summarized in Table 3 . As was found in the PB, no staining with WT31 was identified.
However, f3F1-staining was wen in the neoplastic cells in frozen section studics. This antibody recognizes a diffcrent antigenic cpitope on the T-f3 chain than that identificd by WT31.?" In addition, antibodies against thc T-y and T-6 chains (TCRy-1 and TCRG-I) failcd to show any reactivity by these immunoperoxidase studics. Figure 4 shows the intense cytoplasmic positivity Seen with anti-S100P in the leukemic cclls in the liver and lymph node paraffin sections. The anti-SI00f3 staining pattcrn accentuated the sinusoidal pattern of involvement in the liver and lymph node and showed a more significant involvement in the spleen than could be recognized morphologically. A similar staining pattern was secn with UCHL-1 (CD45RO), a pan-T-cell-associated marker, showing that the neoplastic cells were staining with both antibodies. Other lymphoidassociated, histiocytic-associated, epithelial, and soft tissue antibodies were negative on these paraffin section immuneperoxidase studies. Anti-S100B staining was identified in the BM trephine biopsy sections ofcasc no. 2. 
IgITCR DNA Studies
C h a ! TCR gene rearrangements were Seen in both cases (no. 1 and 2) studied with TCR B, y (Fig 5) . and 6 (data not shown) chain gene Probes. The marked intensity of the rearranged bands indicated that the majority of the cells contained the clonal rearrangements. All rearrangements were confirmed with at least two restriction endonucleases. No Ig gene rearrangements were seen.
Parafin section immunohistochemktty.
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TCR RNA Gene Studies
TCR RNA expression was evaluated by Northem blotting with T-a, T-p, T-y, and T-6 gene probes in cases no. 1 and 2 to determine which of the clonal rearrangements just described were indeed productive and capable of encoding for an intact TCR protein. These Northem blot studies showed normal-sized T-a and T-f3 gene RNA transcripts, indicating that both T-a and T-f3 underwent a productive gene rearrangement (Fig 6) . No T-y or T-6 RNA were identified by Northern blot studies (Fig 6) . These results confirmed that the a / p TCR genes were effectively tranxribed despite having a CD3-positive/m1, CD4, (-33-negative immunophenotype.
Kral DNA and RNA Studies
DNA from PB lymphocytes of cases no. 1 and 2 was probed via Southern blot hybridization for the presence of human retrovirus (HIV-1 and HTLV-1) and heWsvirus (EBV and CMV) genomic DNA. N O hybridization was seen in either case with the resPective Probes*
Cytotoxici~ Assay
Cytotoxicity assays were performed to evaluate the fmction Of the neOpk3StiC Cells in Case no. 1. The patient's Cells showed strong Cytotoxicity for K562 target cells as compared with normal donor lymphocytes ( Table 4) . Only minimal cytotoxic activity was seen when Daudi cells were used as the target cell. These results are consistent with non-MHC-restricted Cytotoxicity, which is a characteristic and defining feature of NK cell function. The non-MHC- No. 4 restricted cytotoxicity of the patient's mononuclear cells was effectively inhibited by the addition of either CD2 or For thought to bc spccific for ncural tissuc, but is now known to bc prcscnt in a varicty of cclls including myocpithclium, mclanocytcs, chondrocytcs, adipocytcs, Langcrhans cclls. intcrdigitating rcticulum cclls, and various carcinoma ccIIs.I" Thc gcnc cncoding thc SI00 antigcn has rcccntly bccn localized to chromosomc 21 band q22.2, but has not bccn further charactcrizcd.'-.' Although wc know this ubiquitous protcin bclongs to the family of calcium-binding protcins, its prccisc role in cellular function rcmains an cnigma.
HW-I, HTLV-I, EBV, and C W .
Rcccntly, scvcral rcports havc dcscribcd rcectivity of anti-SI00f.3 in a small subsct of human PI3 T lymphocytes. Thcsc cclls account for approximatcly 1% to 4% of PB mononuclcar cclls and havc bccn immunologically classificd as suppressor/cytotoxic T cclls bascd on thc cxprcssion of CD2, CD8, and C D l l b antigens."' Thc difficulty in charactcrizing and cvaluating thcsc cclls is that thc SloOp antigcn is locatcd within the ccllular cytoplasm with thc rcsulting cffcct that thcsc cclls cannot bc dircctly sortcd by a flow cytomctcr.
Thc S100-CLPD rcprcscnts a uniquc malignancy having charactcristic clinical and laboratory fcaturcs. Thc four paticnts from our study, along with thc thrcc prcviously rcportcd pati~nts,~'.'" uniformly had massivc hcpatosplcnomcgaly without significant Iymphadcnopathy, and cxhibitcd an sggrcssivc clinical coursc with relatively short survivals. Intcrcstingly, thrcc of our paticnts dcvclopcd documcntcd CNS discasc and two of thc prcviously rcportcd paticnts had signs and symptoms of CNS discasc at thc timc of dcath. Thc PB findings varicd from a normal WBC to a frank lcukcmic picturc. Thcsc paticnts also had thrombocytopcnia without significant ancmia or ncutropcnia. Morphologically. the tumor cclls showcd a charactcristic prcdilcction for thc lymph nodc and hcpatic sinuscs and splcnic rcd Thc abovc fcaturcs arc quitc distinct from othcr T-ccll lymphoprolifcrativc disordcrs. T-y lymphoprolifcrativc disorder (TyLPD), or largc granular lymphocytosis, is typically an indolcnt discasc that is usually associatcd with long survivals and fcw clinical symptoms.'.' Although thc immunophcnotypc of S100-CLPD is similar to that found in TyLPD. TyLPD is scldom associatcd with massivc organomcgaly. Morc importantly, thc largc granular lymphocytcs of TyLPD havc a uniquc cytologic appearancc on both PB smears and ultrastructural studies,J features that were absent from the S100-positive lymphoprolifcrations. Although the aggressive clinical course for these patients was remininscent of an HTLV-I-positive, adult T-ccll leukemia/lymphoma, the lymphocytes in SIOO-CLPD lacked the characteristic hypcrlobulatcd nuclei of adult T-cell leukemia. In addition, this CLPD did not have any obvious BM involvement and was not a CD4-positive. T-cell proliferation.' More importantly, serologic and DNA assays for YTLV-I were negative. Although these cases could be considered as "peripheral T-cell lymphomas" in a broad sense, the histologic pattern of involvement in the liver, spleen, and lymph node, the predilection for splenic involvcment, and the presence of a leukemic proliferation without a BM infiltrate would not be considered characteristic of a typical peripheral T-cell lymphoma." Previous studies of anti-SI00P staining in non-Hodgkin's lymphomas failed to show any S100-positive reactivity in peripheral T-cell lymphomas.".*' Thus, the S100-CLPD have many morphologic and clinical features that are unique as compared with other T-cell malignancies.
The immunophenotypic features and functional studies in our cases were consistent with a proliferation of NK-like cells, expressing CDl lb, CDl IC, CD16, and CDS6 without CDS7. It is now clear that this immunophcnotypc is not solely restricted to "true" NK cells, but can also be found in non-MHC-restricted, cytotoxic T lymphocytes." As compared with the "true" NK cells, which lack any TCR, the non-MHC-restricted cytotoxic T lymphocytes may express either an a/P or y/fi TCR." Thus, the use of the term "NK cell" is quite ambiguous and refers to a heterogeneous group of cells, all exhibiting NK cell activity but with differing antigenic and genotypic features. The molecular studies in the S100-CLPD cases in this report clearly showed multiple TCR gene rearrangements and, more importantly, showed RNA transcripts of both the T-a and T-P genes. Thus, it would appear that these S100-positive cells arc rcprescntivc of the non-MHC-restricted, cytotoxic T lymphocytes rathcr than "true" NK cells.
The initial immunophcnotype of CD3-positivc/WT31, CD4, CDX-negative cclls was strong presumptive evidence for a y/fi TCR."." However, subsequent staining with PFl, lack of reactivity with TCRy-I and TCRfi-1, and the Northern blot studies showing a and P TCR transcripts were evidence that these cells truly had an a / p TCR rathcr than a y/fi TCR. Although unexpected, other reports have also suggested that such a phenotype may exist. Several studies have shown a lack of concordance between CD3, WT31, and/or PFl staining in T-cell malignancies.42 ''
Other investigators have characterized a unique subset of circulating T cells in mice that were CD3-positivc, CD4-negative, and CDR-negative that bore an a / p TCR." Thus, the unexpected finding of a CD3, f3Fl-positivc/CD4, CDX, WT31-negative phenotype and an a / p TCR transcript could rcprcscnt: (1) conformational change of the a/P hctcrodimcr, leading to loss of anti-WT31 expression while still maintaining at least p-chain (PFl) antigenicity; (2) expansion of a heretofore poorly recognized, minor subset of circulating T cells; or (3) aberrant loss of surface antigcn(s) by a neoplastic process.
Many features of this disorder suggest a possible association with a viral transformation. The relative young age group, as compared with most non-Hodgkin's lymphomas, the incidence of CNS involvement, and an aggressive disease course are all characteristics that can be sccn in a viral-induced lymphoid process. Although HTLV-1 was a For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From were consistent with past infection, and DNA hybridization studies in cases no. 1 and 2 failed to show any evidence of EBV genomes. Human herpesvirus-6 (HHVd), originally termed human B-lymphotropic virus, is a newly recognized herpesvirus first isolated from patients with lymphoproliferative disorders?' A recent report from our laborat09 has shown preliminary evidence that S100-CLPD may be associated with HHV-6. Further laboratory studies are in progress to evaluate the potential role that this herpesvirus may have in the development of this uncommon, yet aggressive chronic lymphoproliferative disorder.
